Search
for
Sort by
Research 511–540 of 1000+
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Modeling cell–cell communication for immune systems across space and time
- Original synthetic monophenolic antioxidant with combined effect inhibits tumor growth in vivo
- Chitosan stimulates root hair callose deposition and inhibits root hair growth
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Beneficial effects of finasteride on hepatic and pulmonary immune response after trauma hemorrhage in mice
- Rosmarinus officinalis L. (Rosemary) Extracts Containing Carnosic Acid and Carnosol are Potent Quorum Sensing Inhibitors of Staphylococcus aureus Virulence
- A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats
- 201 Analysis of mice skin distribution using MALDI-MSI after subcutaneous injections of a new potent novel inhibitor of human hair growth, FOL-005
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- BH14 Irish dermatologists’ experience with Janus kinase inhibitors in alopecia areata
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- 845 Dermal lymphatic vessels promote hair follicle growth via the BMP inhibitor Sostdc1
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata